DART has been registered with ISRCTN, using ID 13720905
This includes a Plain English summary under the title “Providing data so computer systems can help with the early identification of lung diseases, leading to more rapid treatment and better survival rates”.
Registration with ISRCTN is the first step towards trial transparency and the future dissemination of health research outcomes. Its key aim is to ensure that all healthcare decisions are informed by all of the available evidence, thus, overcoming publication bias and selective reporting. Registration provides opportunities for collaboration and reduces duplication of research efforts; it also improves awareness of trials for clinicians, researchers, patients and the public.
Unlocking the future of lung cancer screening: How DART is redefining early diagnosis
October 23, 2023
When it comes to the battle against lung cancer, early detection is the key to saving lives. But what if…
Comparing imaging techniques to diagnose lung cancer – looking for advisors
May 25, 2023
CanPredict: Lung cancer risk prediction
April 13, 2023
February 27, 2023